Candela is a leading global non-surgical aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, women's intimate health, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company has a wide portfolio of trusted, leading products including UltraShape Power, VelaShape, CO2RE, CO2RE Intima, GentleMax Pro, VBeam Prima, PicoWay, Profound and elōs Plus. The acquisition of Danish Ellipse adds globally renowned IPL and laser technologies, like Nordlys and Ydun, to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices.